logo
logo
Sign in

Corneal Epithelial Defect Market Size, Industry Analysis, Epidemiology, Pipeline Therapies And Key Companies By DelveInsight

avatar
Ankit Nigam

DelveInsight's Corneal Epithelial Defect Market Insights report provides a thorough understanding of current treatment practices, emerging drugs, Corneal Epithelial Defect market share of the individual therapies, current and forecasted Corneal Epithelial Defect market size from 2018 to 2030 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).

Some facts of Corneal Epithelial Defect Market Report:

·        Corneal Epithelial Defect Market size is expected to change for 7MM during the forecast period of 2018-30.

·        The key driver for the surge in market size is the rise in number of incident cases.

·        As per the study conducted by Wirostko et al. titled “Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone” stated that the estimated number of PCEDs per year in the United States is roughly 73,434−99,465 cases, based on a recent US population of approximately 314,037,169. The total incidence of PCEDs is less than 200,000 in the US, and is therefore considered an orphan disease in this region.

·        Abdel‐Naby et al. conducted a study titled “Silk‐Derived Protein Enhances Corneal Epithelial Migration, Adhesion, and Proliferation” mentioned that annually, over 50 million people worldwide suffer from blindness as a result of corneal disease with nearly 2.5 million new eye injuries occurring each year in the United States.

·        According to a study conducted by Chen et al. titled “Corneal persistent epithelial defect after pars plana vitrectomy” wherein the results showed that postoperative corneal complications developed in 103 of 460 (22.4%) eyes. Among 103 eyes with corneal complications, 21 eyes developed PCED. The eyes with PCED had poor final visual acuity, with 23.8% of the eyes in the PCED group having visual acuity of 20 per 200 or better compared with 51.2% of the eyes in the non‐PCED group.

To get more detailed insight on Corneal Epithelial Defect Market Report @Request for a Sample Report here: https://www.delveinsight.com/sample-request/corneal-epithelial-defect-market

View Report: https://www.delveinsight.com/report-store/corneal-epithelial-defect-market

Some of Corneal Epithelial Defect Companies are:

·        Noveome Biotherapeutics

·        Santen Pharmaceutical

·        Eyegate Pharma

·        And Many Others

To get more detailed insight on Corneal Epithelial Defect Key Players @Request for a Sample Report here: https://www.delveinsight.com/sample-request/corneal-epithelial-defect-market

View Report: https://www.delveinsight.com/report-store/corneal-epithelial-defect-market

Corneal Epithelial Defect Therapies are:

·        ST266

·        DE‐105

·        Ocular bandage gel (OBG)

·        And Many Others


DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

Related Reports:


About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.



collect
0
avatar
Ankit Nigam
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more